CD4 and pancreatic neoplasm: The aforementioned animal results suggest that targeting apCAFs by αMSLN can reverse the immunosuppressive microenvironment of pancreatic cancer, whereas the correlation among apCAFs, CD8+ T cells and IFN‐γ+CD4+ T cells in pancreatic cancer remain unclear.